KBC Securities advice for Oxurion
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| February 13, 2014 | KBC Securities | Oxurion | Buy | 33.00 EUR |
Advice details
Brussel - Op 13 Feb 2014 herhalen de analisten van KBC Securities hun koopadvies voor the Belgian biopharmaceutical company Oxurion (ISIN: BE0003846632 / Mnemo: THR). Het 12-maands koersdoel blijft gehandhaafd op 33.0 EUR.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 